454-55-7Relevant articles and documents
TRPA1 ANTAGONISTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH PAIN AND INFLAMMATION
-
, (2021/11/26)
The present invention is directed to compounds of general formula (I) as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions comprising said compounds,
The modified trifluoromethylation protocol applicable to electronically deficient iodopyridinones
Kawasaki-Takasuka, Tomoko,Yamazaki, Takashi
, p. 6824 - 6831 (2015/08/24)
Utilization of a mixed solvent system of DMF/HMPA=1/1 (v/v) to the KF/CuI/TMSCF3 reagent system proved to significantly affect the reaction, realizing convenient introduction of a trifluoromethyl (CF3) group not only to electron-deficient iodopyridinones with quite a few previous successful examples but also to aliphatic vinylic iodides.
Trifluoromethylation of alkenes by visible light photoredox catalysis
Iqbal, Naeem,Choi, Sungkyu,Kim, Eunjin,Cho, Eun Jin
, p. 11383 - 11387 (2013/03/13)
A method for trifluoromethylation of alkenes has been developed employing visible light photoredox catalysis with CF3I, Ru(Phen) 3Cl2, and DBU. This process works especially well for terminal alkenes to give alkenyl-CF3 products with only E-stereochemistry. The mild reaction conditions enable the trifluoromethylation of a range of alkenes that bear various functional groups.